These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 20332211

  • 1. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
    Sheriff S, Ali M, Yahya A, Haider KH, Balasubramaniam A, Amlal H.
    Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
    [Abstract] [Full Text] [Related]

  • 2. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
    Amlal H, Faroqui S, Balasubramaniam A, Sheriff S.
    Cancer Res; 2006 Apr 01; 66(7):3706-14. PubMed ID: 16585197
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
    Medeiros PJ, Jackson DN.
    Peptides; 2013 Oct 01; 48():106-13. PubMed ID: 23932937
    [Abstract] [Full Text] [Related]

  • 4. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
    Gehlert DR, Schober DA, Morin M, Berglund MM.
    Biochem Pharmacol; 2007 Dec 03; 74(11):1652-64. PubMed ID: 17897631
    [Abstract] [Full Text] [Related]

  • 5. Neuropeptide Y modulates steroid production of human adrenal H295R cells through Y1 receptors.
    Kempná P, Körner M, Waser B, Hofer G, Nuoffer JM, Reubi JC, Flück CE.
    Mol Cell Endocrinol; 2010 Jan 15; 314(1):101-9. PubMed ID: 19699258
    [Abstract] [Full Text] [Related]

  • 6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 7. Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
    Medeiros PJ, Al-Khazraji BK, Novielli NM, Postovit LM, Chambers AF, Jackson DN.
    Int J Cancer; 2012 Jul 15; 131(2):276-86. PubMed ID: 21823118
    [Abstract] [Full Text] [Related]

  • 8. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
    Igura K, Haider HKh, Ahmed RP, Sheriff S, Ashraf M.
    Rejuvenation Res; 2011 Aug 15; 14(4):393-403. PubMed ID: 21595512
    [Abstract] [Full Text] [Related]

  • 9. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J, Kitlinska J, Ji H, Lee EW, Zukowska Z.
    Can J Physiol Pharmacol; 2003 Feb 15; 81(2):177-85. PubMed ID: 12710532
    [Abstract] [Full Text] [Related]

  • 10. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
    Liu X, Wu WK, Yu L, Sung JJ, Srivastava G, Zhang ST, Cho CH.
    J Cell Biochem; 2008 Sep 01; 105(1):53-60. PubMed ID: 18452159
    [Abstract] [Full Text] [Related]

  • 11. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
    Dumont Y, Cadieux A, Doods H, Fournier A, Quirion R.
    Can J Physiol Pharmacol; 2000 Feb 01; 78(2):116-25. PubMed ID: 10737674
    [Abstract] [Full Text] [Related]

  • 12. Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.
    Reubi JC, Gugger M, Waser B, Schaer JC.
    Cancer Res; 2001 Jun 01; 61(11):4636-41. PubMed ID: 11389101
    [Abstract] [Full Text] [Related]

  • 13. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
    Criscione L, Rigollier P, Batzl-Hartmann C, Rüeger H, Stricker-Krongrad A, Wyss P, Brunner L, Whitebread S, Yamaguchi Y, Gerald C, Heurich RO, Walker MW, Chiesi M, Schilling W, Hofbauer KG, Levens N.
    J Clin Invest; 1998 Dec 15; 102(12):2136-45. PubMed ID: 9854049
    [Abstract] [Full Text] [Related]

  • 14. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z, Hodges VM, Dunlop EA, Percy MJ, Maxwell AP, El-Tanani M, Lappin TR.
    Mol Cancer Res; 2010 Apr 15; 8(4):615-26. PubMed ID: 20353997
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R.
    Neuropeptides; 2004 Aug 15; 38(4):163-74. PubMed ID: 15337369
    [Abstract] [Full Text] [Related]

  • 16. Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
    Dhillon SS, Gingerich S, Belsham DD.
    Regul Pept; 2009 Aug 07; 156(1-3):96-103. PubMed ID: 19371763
    [Abstract] [Full Text] [Related]

  • 17. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
    Moriya R, Mashiko S, Ishihara A, Takahashi T, Murai T, Ito J, Mitobe Y, Oda Z, Iwaasa H, Takehiro F, Kanatani A.
    Peptides; 2009 Jul 07; 30(7):1318-22. PubMed ID: 19394383
    [Abstract] [Full Text] [Related]

  • 18. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
    Ammar DA, Hughes BA, Thompson DA.
    Invest Ophthalmol Vis Sci; 1998 Sep 07; 39(10):1870-8. PubMed ID: 9727410
    [Abstract] [Full Text] [Related]

  • 19. The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis.
    Yokosuka M, Dube MG, Kalra PS, Kalra SP.
    Peptides; 2001 Mar 07; 22(3):507-14. PubMed ID: 11287108
    [Abstract] [Full Text] [Related]

  • 20. Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells.
    Ruscica M, Dozio E, Boghossian S, Bovo G, Martos Riaño V, Motta M, Magni P.
    Endocrinology; 2006 Mar 07; 147(3):1466-73. PubMed ID: 16339211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.